Mid-Cap

One healthcare stock that plunged on profit downgrade

July 11, 2016 | Team Kalkine
One healthcare stock that plunged on profit downgrade

Primary Health Care Ltd


PRY Details
  • Profit estimate downgrade: Primary Health Care Ltd (ASX: PRY) stock fell 2.4% on July 11, 2016 after the company gave the weak trading update. After the balance sheet review and finalization of FY 2016, PRY expects to incur over $98 million in after?tax non?cash write offs. Out of these write?offs, $32 million is required to be accounted for prior periods and $66 million in the current year. Moreover, the impact on the profit after tax (NPAT) for FY2016 would be partially offset by $30 million of profit on sales of Medical Director and Transport Health, in addition to those items which were announced at the half year results for 2016. However, PRY had expected to meet the bottom end of its forecast range of $110 million to $115 million in case of normal trading conditions. But, they estimate to incur a write?off of about $4 million for the balance sheet review and a further adjustment of $2 million for the sale of Medical Director six weeks earlier than expected.  Accordingly, the group updated its underlying NPAT estimates to over $104 million for FY2016.
  • Recommendation: Given such pressure in the group’s bottom line performance, we give an “Expensive” recommendation on the stock at the current price of $3.73

Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376).The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd currently hold positions in:  BHP, BKY, KCN, PDN, and RIO. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.